In 2016, for the first time, Bo and colleagues have demonstrated that inhibiting HMGB-1 suppresses the proliferation of HESCs, indicating that targeting HMGB-1 might be a strategy for endometriosis therapy (20). This evidence concerns the gene HMGB1 and endometriosis.